These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11950861)

  • 1. Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency.
    Hanawa H; Watanabe K; Nakamura T; Ogawa Y; Toba K; Fuse I; Kodama M; Kato K; Fuse K; Aizawa Y
    J Med Genet; 2002 Apr; 39(4):286-91. PubMed ID: 11950861
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of exon skipping mutants of the COP1 gene from Arabidopsis.
    Simpson CG; McQuade C; Lyon J; Brown JW
    Plant J; 1998 Jul; 15(1):125-31. PubMed ID: 9744100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
    Sharp A; Pichert G; Lucassen A; Eccles D
    Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer function.
    Shariat N; Holladay CD; Cleary RK; Phillips JA; Patton JG
    Clin Genet; 2008 Dec; 74(6):539-45. PubMed ID: 18554279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping.
    Divina P; Kvitkovicova A; Buratti E; Vorechovsky I
    Eur J Hum Genet; 2009 Jun; 17(6):759-65. PubMed ID: 19142208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
    Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
    Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.
    Niba ETE; Nishida A; Tran VK; Vu DC; Matsumoto M; Awano H; Lee T; Takeshima Y; Nishio H; Matsuo M
    J Hum Genet; 2017 Apr; 62(5):531-537. PubMed ID: 28100912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of ectopic factor VIII transcripts from hemophilia A patients: identification of cryptic splice site, exon skipping and novel point mutations.
    Tavassoli K; Eigel A; Pollmann H; Horst J
    Hum Genet; 1997 Oct; 100(5-6):508-11. PubMed ID: 9341862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.
    McVety S; Li L; Gordon PH; Chong G; Foulkes WD
    J Med Genet; 2006 Feb; 43(2):153-6. PubMed ID: 15923275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.
    Costantino L; Claut L; Paracchini V; Coviello DA; Colombo C; Porcaro L; Capasso P; Zanardelli M; Pizzamiglio G; Degiorgio D; Seia M
    J Cyst Fibros; 2010 Dec; 9(6):411-8. PubMed ID: 20875776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects.
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Hum Mutat; 1999; 14(5):359-68. PubMed ID: 10533061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
    Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
    Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
    Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC.
    Kern P; Kolowos W; Hagenhofer M; Frank C; Kalden JR; Herrmann M
    Eur J Immunogenet; 1999 Oct; 26(5):337-42. PubMed ID: 10553499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon junction sequences as cryptic splice sites: implications for intron origin.
    Sadusky T; Newman AJ; Dibb NJ
    Curr Biol; 2004 Mar; 14(6):505-9. PubMed ID: 15043816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
    Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
    Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective IgG2 deficiency due to a point mutation causing abnormal splicing of the Cgamma2 gene.
    Zhao Y; Pan-Hammarström Q; Zhao Z; Wen S; Hammarström L
    Int Immunol; 2005 Jan; 17(1):95-101. PubMed ID: 15569770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene.
    Bespalova IN; Pranzatelli M; Burmeister M
    Mutat Res; 1997 Sep; 382(1-2):67-74. PubMed ID: 9360639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.